North American peptide therapeutics market is estimated to project a CAGR of 5.1%, during the forecast period. The high per capita healthcare expenditure coupled with the increasing investment in modern healthcare technologies are the key factors that are anticipated to drive the growth of the peptide therapeutics market in the region. Pfizer Inc., Merck & Co. Inc., Eli Lilly, and Co., and GlaxoSmithKline Plc among others are some of the global key players of the peptide therapeutics market operating in the region.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-peptide-therapeutics-market
The North American peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into parenteral administration and oral administration. On the basis of application, the market is segmented into cancer, metabolic disorder (diabetes & obesity), gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others including chronic kidney diseases, osteoporosis, and autoimmune disorder. Among these applications, metabolic disorder dominates the market in North America. The increasing prevalence of diabetes created the demand for insulin and hence drives market growth.
A full report of North American Peptide Therapeutics Market available @ https://www.omrglobal.com/industry-reports/north-american-peptide-therapeutics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
North American Peptide Therapeutics Market by Route of Administration
- Oral
- Parenteral
North American Peptide Therapeutics Market by Application
- Cancer
- Metabolic Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others (Kidney Disorder and Autoimmune Disorder)
Regional Analysis
- United States
- Canada
Company Profiles
- Amgen, Inc.
- Overview
- Amgen Inc. in North America
- Amgen Inc. in Peptide Therapeutics Landscape
- Recent Developments
- AstraZeneca PLC
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Xenetic Biosciences, Inc.
The Report Covers:
- Comprehensive research methodology of the North American peptide therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American peptide therapeutics market.
- Insights about market determinants which are stimulating the North American peptide therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
